Pedro M. Cardoso

Exeter, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care data.

Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care data.

Journal: The Lancet. Primary care
Published: May 11, 2026

Trends in Second-Line Initiations and Treatment Outcomes Across Age and Frailty Groups in People With Type 2 Diabetes: UK Population-Based Study, 2019-2024.

Trends in Second-Line Initiations and Treatment Outcomes Across Age and Frailty Groups in People With Type 2 Diabetes: UK Population-Based Study, 2019-2024.

Journal: Diabetes, obesity & metabolism
Published: March 30, 2026

GLP-1RA precision medicine in people with type 2 diabetes: current insights and future prospects.

GLP-1RA precision medicine in people with type 2 diabetes: current insights and future prospects.

Journal: The Journal of clinical investigation
Published: January 16, 2026

Type 2 diabetes subtypes for precision medicine: methodological challenges and alternative prediction-based approaches.

Type 2 diabetes subtypes for precision medicine: methodological challenges and alternative prediction-based approaches.

Journal: Diabetologia
Published: January 05, 2026

Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study.

Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study.

Journal: Diabetes care
Published: December 09, 2025

Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study.

Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study.

Journal: The Lancet regional health. Europe
Published: August 26, 2025

Estimating the benefits of personalised glycaemic control - Authors' reply.

Estimating the benefits of personalised glycaemic control - Authors' reply.

Journal: Lancet (London, England)
Published: June 19, 2025

Updating a Clinical Prediction Model for Identifying Monogenic Diabetes to Include Both Clinical Features and Biomarkers.

Updating a Clinical Prediction Model for Identifying Monogenic Diabetes to Include Both Clinical Features and Biomarkers.

Journal: Diabetes care
Published: May 02, 2025

Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study.

Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study.

Journal: Diabetes, obesity & metabolism
Published: March 11, 2025

A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study.

A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study.

Journal: Lancet (London, England)
Published: October 03, 2024

Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570.

Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570.

Journal: Diabetes care
Published: April 30, 2024

Comparison of Bayesian approaches for developing prediction models in rare disease: application to the identification of patients with Maturity-Onset Diabetes of the Young.

Comparison of Bayesian approaches for developing prediction models in rare disease: application to the identification of patients with Maturity-Onset Diabetes of the Young.

Journal: BMC medical research methodology
Published: January 12, 2024
Showing 1-12 of 14

Last Updated: 09/26/2026